Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K1UF
|
||||
Former ID |
DIB016089
|
||||
Drug Name |
Saliphenylhalamide
|
||||
Synonyms |
RTA-203; Saliphenylhalamide (cancer); Saliphenylhalamide (cancer), Reata; V-ATPase inhibitor (cancer), Reata; Vacuolar H+-ATPase inhibitors (anticancer), Reata
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543965] | ||
Company |
Reata Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C28H29NO5
|
||||
Canonical SMILES |
c1ccc2c(c1O)C(=O)O[C@H](C[C@H]([C@H](C/C=C/C2)C)O)C/C=C<br />/NC(=O)C#Cc1ccccc1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium-transporting ATPase alpha chain 1 | Target Info | Inhibitor | [543965] | |
PathWhiz Pathway | Gastric Acid Production | ||||
Reactome | Ion transport by P-type ATPases | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.